159 related articles for article (PubMed ID: 17168362)
1. [Prognostic models for Hodgkin's disease].
Panyshin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):538-43. PubMed ID: 17168362
[TBL] [Abstract][Full Text] [Related]
2. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
Kharchenko VP; Datsenko PV; Panyshin GA; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):531-7. PubMed ID: 17168361
[TBL] [Abstract][Full Text] [Related]
3. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
Rueffer U; Sieber M; Stemberg M; Gossmann A; Josting A; Koch T; Grotenhermen F; Diehl V;
Ann Hematol; 2003 Jul; 82(7):390-6. PubMed ID: 12764547
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of the lung lesions in lymphogranulomatosis].
Simbirtseva LP; Gubareva AV; Sheĭdakov AA; Skripkina NS
Vopr Onkol; 1984; 30(2):40-5. PubMed ID: 6702130
[TBL] [Abstract][Full Text] [Related]
5. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease].
Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Golovanov SG
Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808
[TBL] [Abstract][Full Text] [Related]
6. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
Koumarianou AA; Xiros N; Papageorgiou E; Pectasides D; Economopoulos T
Anticancer Res; 2007; 27(2):1191-7. PubMed ID: 17465262
[TBL] [Abstract][Full Text] [Related]
7. [Outcomes prediction for children with Hodgkin's disease].
Kolygin BA; Anishkin MIu
Vopr Onkol; 2006; 52(3):322-5. PubMed ID: 17191706
[TBL] [Abstract][Full Text] [Related]
8. [Generic symptoms of Hodgkin's disease in relation to other prognostic criteries (author's transl)].
Pemsel HK; Jacobs C; Hess F; Kalbfleisch H
Strahlentherapie; 1978 Nov; 154(11):758-65. PubMed ID: 715807
[TBL] [Abstract][Full Text] [Related]
9. Role of bone marrow trephine biopsy in the diagnosis of marrow involvement in Hodgkin's disease.
Subramanian R; Basu D; Badhe B; Dutta TK
Indian J Pathol Microbiol; 2007 Jul; 50(3):640-3. PubMed ID: 17883170
[TBL] [Abstract][Full Text] [Related]
10. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
[TBL] [Abstract][Full Text] [Related]
11. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R; Maeda L; Lavori P; Quon A; Hoppe R; Breslin S; Rosenberg SA; Horning SJ
J Clin Oncol; 2007 Sep; 25(25):3902-7. PubMed ID: 17664458
[TBL] [Abstract][Full Text] [Related]
12. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
14. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?].
Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410
[TBL] [Abstract][Full Text] [Related]
15. [The story about Hodgkin's lymphoma].
Ostojić Kolonić S
Acta Med Croatica; 2008 Oct; 62(4):409-12. PubMed ID: 19205418
[TBL] [Abstract][Full Text] [Related]
16. The pathologist's role in management of patients with Hodgkin's disease.
Dorfman RF; Colby TV
Cancer Treat Rep; 1982 Apr; 66(4):675-80. PubMed ID: 7074637
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for bone marrow involvement in Hodgkin's disease].
Kanaev SV; Novikov SN; Zhukova LA; Pozharisskiĭ KM; Leenman EE; Gershanovich ML
Vopr Onkol; 2001; 47(1):39-44. PubMed ID: 11317533
[TBL] [Abstract][Full Text] [Related]
18. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
19. [Has surgery improved the prognosis of Hodgkin's disease?].
Tarquini A; Malloci A
Minerva Chir; 1980 Jan 15-31; 35(1-2):45-52. PubMed ID: 7393462
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of invasive non-Hodgkin's lymphoma].
Yu H; Hong XN; Li J; Peng LP; Ye L
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
